Objective-To determine trends in total prevalence ofneural tube defects in South Australia during 1966-91, the impact of prenatal diagnosis on birth prevalence, and the effectiveness ofprenatal screening for neural tube defects in 1986-91.
Introduction
Neural tube defects, which include anencephaly, spina bifida, and encephalocele, are an important group of severe birth defects whose prevalence has fallen over the past six decades in many countries. The fall has been attributed to natural causes in some countries-for example, in the Republic of Ireland, where screening programmes and terminations of pregnancy are not available' 2 and in the United Kingdom, the Netherlands, Sweden, Hungary, and the United States before screening programmes were established in the 1980s."' In Australia the natural fall in prevalence initially reported in three states from 1976 to 19818 was not sustained after 1981. 9 The introduction of antenatal ultrasonography and population based maternal serum a fetoprotein screening programmes in the late 1970s has enhanced the natural fall in prevalence.2 I'll The impact of prenatal diagnosis cannot be assessed when statistics on terminations of pregnancy are lacking,0 1' but where these statistics are available stable prevalence or fluctuations in prevalence with no time trends have been reported. 2 We conducted this study to determine the total prevalence of neural tube defects in South Australia for the years 1966-91, the impact of prenatal diagnosis on birth prevalence (excluding terminations) during this period, and the effectiveness of prenatal screening for neural tube defects in 1986-91. South Australia has a population of 1 4 Results Table I shows the total prevalence and birth prevalence ofneural tube defects in South Australia for 1966-91. Figures 1 and 2 show the total prevalence and birth prevalence for all neural tube defects and for individual defects. As there were no terminations for neural tube defects until 1978, total prevalence and birth prevalence were the same for 1966-77.
The annual total prevalence of neural tube defects in South Australia in 1966-91 fluctuated between 1-49 and 2 37/1000 births with no upward or downward ultrasonography, or both, were included-that is, 227 women with affected babies in 1986-91-the percentage of cases detected prenatally before 28 weeks' gestation was 85% (81% to 90%). The corresponding percentages for individual defects were 99% for anencephaly, 76% for spina bifida, and 64% for encephalocele. Only five of the 194 cases detected before 28 weeks' gestation were detected after 20 weeks' gestation by ultrasound examination.
Discussion
The study has shown that the total prevalence of neural tube defects in South Australia was stable during 1966-91 but that the birth prevalence fell greatly because of effective prenatal diagnosis and termination ofpregnancy.
As spontaneous loss of fetuses with neural tube defects occurs, prenatal detection and termination of affected fetuses before 20 weeks' gestation may have resulted in some cases being included in the total prevalence for 1978-91 that would have been excluded from the data collected before 1978 because they had aborted spontaneously. Creasy and of two fetuses in 1988, 1990, and 1991 . Excluding these fetuses did not affect the conclusion of an absence oftrend in the total prevalence ofall neural tube defects for 1966-9 1 (Poisson regression analysis, p=0 77) or of anencephaly, the defect contributing the largest proportion of terminations (p= 0.21).
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Public health implications The impact of prenatal diagnosis on birth prevalence is dependent not only on the sensitivity of the screening programme but also on the uptake of testing by doctors and pregnant women, presentation for antenatal care in time for screening and legal termination of pregnancy, and the attitude to termination of pregnancy ofcouples with affected fetuses.
Our results show the value of population based registers in accurate ascertainment of birth defects, which enables assessment of the effect of preventive strategies. The centralised maternal serum a fetoprotein screening programme facilitated ascertainment. Folate has been shown to reduce the rate of neural tube defects when taken before conception and in the early months of pregnancy. '9 20 There is no formal policy on the use of folate before conception in South Australia, but the Australian National Health and Medical Research Council has recommended that women who have had an affected pregnancy or have a family history of neural tube defect should be offered genetic counselling and folic acid supplements around the time of conception (5 mg daily). The council has also recently recommended (115th session, Adelaide, June 1993) that women in low risk groups should take 0 5 mg of folic acid daily around the time of conception, that all women of childbearing age should be encouraged to increase their intake of folate rich foods, and that staple foods should be fortified with folic acid.
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